Literature DB >> 119584

Ftorafur: a self-limiting source of 5-fluorouracil?

L M van Putten, P Lelieveld, C Pantarotto, M Salmona, F Spreafico.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 119584     DOI: 10.1007/bf00254422

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  13 in total

1.  Intermittent high single-dose ftorafur: phase I clinical trial with a pharmacologic-toxicity correlation.

Authors:  S W Hall; M Valdivieso; R S Benjamin
Journal:  Cancer Treat Rep       Date:  1977-11

2.  Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens.

Authors:  C Pantarotto; R Fanelli; S Filippeschi; T Facchinetti; F Spreafico; M Salmona
Journal:  Anal Biochem       Date:  1979-09-01       Impact factor: 3.365

3.  Application of gas chromatography-chemical ionization mass fragmentography in the evaluation of bases and nucleoside analogues used in cancer chemotherapy.

Authors:  C Pantarotto; A Martini; G Belvedere; A Bossi; M G Donelli; A Frigerio
Journal:  J Chromatogr       Date:  1974-11-06

4.  Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.

Authors:  L M Van Putten; P Lelieveld; L K Kram-Idsenga
Journal:  Cancer Chemother Rep       Date:  1972-12

5.  Effect of Ftorafur on acid phosphatase activity in the liver of mice with transplanted lymphatic leukaemia.

Authors:  O Carević; V Sverko; M Boranić
Journal:  Experientia       Date:  1974-03-15

6.  Results of treatment of malignant tumors with ftorafur.

Authors:  N G Blokhina; E K Vozny; A M Garin
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

7.  Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.

Authors:  B T Garibjanian; R K Johnson; I Kline; S Vadlamudi; M Gang; J M Venditti; A Goldin
Journal:  Cancer Treat Rep       Date:  1976-09

8.  [Clinical evaluation of Ftorafur (author's transl)].

Authors:  K Rieche; M L Matthes
Journal:  Arch Geschwulstforsch       Date:  1975

9.  Clinical evaluation of ftorafur (pyrimidine-deoxyribose n1-2'-furanidyl-5-fluorouracil).

Authors:  M Valdivieso; G P Bodey; J A Gottlieb; E J Freireich
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

10.  Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice.

Authors:  R K Johnson; B T Garibjanian; D P Houchens; I Kline; M R Gaston; A B Syrkin; A Goldin
Journal:  Cancer Treat Rep       Date:  1976-09
View more
  2 in total

1.  Comparing cell kinetic studies of the effect of ftorafur and 5-fluorouracil on the L 1210 ascites tumor.

Authors:  B Schultze; W Jellinghaus; G Weis; V Müller; W Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

2.  Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.

Authors:  S Palmeri; V Gebbia; A Russo; M G Armata; N Gebbia; L Rausa
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.